IP Library › Granted Patent US 11,850,324
Granted Patent B2
US 11,850,324 · App. 16/341,360 · Granted Dec 26, 2023

Three-dimensional (3-D) printing inks made from natural extracellular matrix molecules

Inventors: David Bagley (San Diego, CA); Bowman Bagley (Carlsbad, CA); Dale Peterson (Carlsbad, CA)
Assignee: Advanced Biomatrix, Inc.
A61L27/26A61L27/3633B29C64/188B29C64/40B33Y70/10B29K2089/00B33Y10/00B33Y40/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,850,324
App. No.
16/341,360
Granted
Dec 26, 2023
Kind
B2
Abstract

The present invention relates to bioinks based on undenatured collagen, kits containing the same, and methods of printing three-dimensional structures using the bioinks.

Claims (19)

1. A bioink comprising undenatured collagen at a concentration of greater than 20 mg/ml, wherein the bioink comprises less than 10% denatured collagen, and wherein the bioink has a static stiffness of about 100 to about 150,000 Pa and a shear stiffness of less than about 50 Pa at a shear rate greater than 0.001 sec −1 at room temperature.

2. The bioink of claim 1 , wherein the bioink gels at a temperature greater than 10° C. when neutralized.

3. The bioink of claim 1 , wherein the collagen is a type I collagen.

4. The bioink of claim 1 , wherein the collagen is telocollagen, atelocollagen, or a mixture thereof.

5. The bioink of claim 1 , comprising more than one type of collagen.

6. The bioink of claim 1 , wherein collagen is the only extracellular matrix protein in the bioink.

7. The bioink of claim 1 , wherein the collagen is modified with chemical groups that permit crosslinking of the collagen.

8. The bioink of claim 1 , wherein the collagen can be crosslinked without chemical modification of the collagen, optionally with a photoinitiator and light exposure.

9. The bioink of claim 8 , wherein the collagen can be crosslinked with a photoinitiator and light exposure.

10. The bioink of claim 1 , further comprising an additive, optionally a crosslinker, a stiffener, a synthetic material, or any combination thereof.

11. The bioink of claim 10 , wherein the additive is a protein, glycosaminoglycan, growth factor, or any combination thereof or wherein the additive is an extracellular matrix molecule, decellularized tissue, or any combination thereof.

12. The bioink of claim 1 , wherein the bioink further comprises a different extracellular matrix molecule.

13. The bioink of claim 1 , wherein the bioink further comprises cells.

14. The bioink of claim 1 , wherein the bioink can be used to print 3-D structures at room temperature.

15. A thixotropic bioink comprising undenatured collagen at a concentration of greater than 20 mg/ml, with a static stiffness of 100 to 150,000 Pa and a shear stiffness of less than about 50 Pa at a shear rate of greater than 0.001 sec −1 that regains at least 20% of its static stiffness within 15 minutes of printing.

16. A kit for preparation of the bioink of claim 1 , the kit comprising undenatured collagen, wherein the undenatured collagen is present in a solution at a concentration of greater than 20 mg/ml.

17. A method of printing a 3-D structure comprising undenatured collagen, the method comprising using the bioink of claim 1 in a 3-D printer.

18. The method of claim 17 , further comprising crosslinking the 3-D structure as it is printed or after it is printed or changing the temperature of the 3-D structure as it is printed or after it is printed or exposing the 3-D structure to light as it is printed or after it is printed.

19. The method of claim 17 , wherein the bioink is printed into a support media, optionally wherein the support media provides temporary support to the 3-D structure, optionally wherein the temporary support is provided by a slurry of hydrogel particles.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 6, 2019
From: BAGLEY, DAVID; BAGLEY, BOWMAN; PETERSON, DALE
To: ADVANCED BIOMATRIX, INC.
Reel/Frame 049091/0709 →
Continuity (3)
Provisional Application 62536727 · Jul 25, 2017
Provisional Application 62406977 · Oct 12, 2016
Related Publication 20200179563A1 · Jun 11, 2020